Plasmatic renin activity in patients treated with L-dopa and inhibitor of dopa decarboxylase (IDC)
- PMID: 108737
- DOI: 10.1007/BF00426736
Plasmatic renin activity in patients treated with L-dopa and inhibitor of dopa decarboxylase (IDC)
Abstract
Plasmatic renin activity (PRA) was studied in patients receiving L-dopa, together with a decarboxylase inhibitor, at rest times and after periods of physical exertion. Although we can superimpose the results from unrelated Parkinson's disease patients on those of the control group, the results are inversed in stabilized patients (lowered PRA) and dyskinetic patients (increased PRA). There is a definite correlation between the increase in PRA and intensity of the dyskinesia. Dosage is the only other factor differentiating the two groups of Parkinsonians treated. The figures relative to arterial pressure are studied in the various groups.
Similar articles
-
The use of bromocriptine for testing central dopaminergic reactivity.Psychopharmacology (Berl). 1980;70(3):313-5. doi: 10.1007/BF00427893. Psychopharmacology (Berl). 1980. PMID: 6777808
-
Effects of levodopa alone and in combination with dopa-decarboxylase inhibitors on plasma renin activity in patients with Parkinson's disease.J Neurol Neurosurg Psychiatry. 1978 Oct;41(10):915-8. doi: 10.1136/jnnp.41.10.915. J Neurol Neurosurg Psychiatry. 1978. PMID: 731241 Free PMC article.
-
Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs.J Pharmacol Exp Ther. 1977 Jul;202(1):209-15. J Pharmacol Exp Ther. 1977. PMID: 874815
-
Parkinson's Disease: Recent Updates in the Identification of Human Dopa Decarboxylase Inhibitors.Curr Drug Metab. 2016;17(5):513-8. doi: 10.2174/138920021705160324170558. Curr Drug Metab. 2016. PMID: 27025882 Review.
-
L-dopa therapy for Parkinson's disease: past, present, and future.Parkinsonism Relat Disord. 2009 Jan;15 Suppl 1:S3-8. doi: 10.1016/S1353-8020(09)70004-5. Parkinsonism Relat Disord. 2009. PMID: 19131039 Review.
Cited by
-
The use of bromocriptine for testing central dopaminergic reactivity.Psychopharmacology (Berl). 1980;70(3):313-5. doi: 10.1007/BF00427893. Psychopharmacology (Berl). 1980. PMID: 6777808
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials